The invention consists of an early diagnosis method for colorectal cancer (CRC) from blood samples.
A new drug to delay the spread of ovarian cancer, which was developed from UCL research, has been licensed for use in the UK.
Researchers from KU Leuven and the Francis Crick Institute have pinpointed 27 novel genes thought to prevent cancer from forming. Their findings could help develop personalised cancer treatments that target these genes.
The rogue messengers can be detected in blood and this may lead to the development of a blood test to help identify patients more susceptible to treatment resistance
Science|Business journalists track important R&D policy news across the globe - including the EU Horizon programme, COVID-19, AI and climate.
Get the twice-weekly newsletter.
A one-stop-shop for tools and information sources supporting the ongoing efforts to defeat the COVID-19 pandemic.
Read more >>
The unique forum convening public and private sector leaders for networking, intelligence and debates on research and innovation.
These updates are republished press releases and communications from members of the Science|Business Network
Tweets by scibus